You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

CEFUROXIME SODIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for cefuroxime sodium and what is the scope of patent protection?

Cefuroxime sodium is the generic ingredient in seven branded drugs marketed by B Braun, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma, Hospira Inc, Teva Pharms, Watson Labs Inc, Samson Medcl, Acs Dobfar, Lilly, and Pai Holdings Pharm, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for cefuroxime sodium. Three suppliers are listed for this compound.

Summary for CEFUROXIME SODIUM
US Patents:0
Tradenames:7
Applicants:11
NDAs:20
Drug Master File Entries: 16
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 104
Clinical Trials: 3
Patent Applications: 1,382
What excipients (inactive ingredients) are in CEFUROXIME SODIUM?CEFUROXIME SODIUM excipients list
DailyMed Link:CEFUROXIME SODIUM at DailyMed
Recent Clinical Trials for CEFUROXIME SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hospital Universitari Vall d'Hebron Research InstitutePhase 4
University Hospital, Basel, SwitzerlandPhase 4
PriCara, Unit of Ortho-McNeil, Inc.Phase 2/Phase 3

See all CEFUROXIME SODIUM clinical trials

Pharmacology for CEFUROXIME SODIUM

US Patents and Regulatory Information for CEFUROXIME SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INJECTION 064035-002 Feb 26, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly KEFUROX IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INTRAVENOUS 062590-001 Jan 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INJECTION 065046-001 Jan 9, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pai Holdings Pharm ZINACEF IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 050643-002 Apr 28, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar KEFUROX cefuroxime sodium INJECTABLE;INJECTION 062591-002 Jan 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar Spa CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INJECTION 064125-002 May 30, 1997 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar KEFUROX cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 062591-001 Jan 10, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.